People's Welfare Pharmaceuticals: Approval Obtained for Quinacetone Ethinyl Estradiol Tablets

Renfu Pharmaceutical Notice: The holding subsidiary Wuhan Jiulong Renfu Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" for the approval and issuance of the Levonorgestrel Ethinylestradiol Tablets from the National Medical Products Administration. This drug is used for female contraception. The company submitted the application for market approval in March 2024 and has been accepted, with a total research and development investment of approximately 8.5 million yuan. The national sales of Levonorgestrel Ethinylestradiol Tablets in 2024 are expected to be around 320 million yuan. This approval signifies that the company is qualified to sell this drug in the domestic market, further enriching the company's product line and positively impacting the company's business.